首页> 外文期刊>Frontiers in Medicine >Case Report: Identification of SARS-CoV-2 in Cerebrospinal Fluid by Ultrahigh-Depth Sequencing in a Patient With Coronavirus Disease 2019 and Neurological Dysfunction
【24h】

Case Report: Identification of SARS-CoV-2 in Cerebrospinal Fluid by Ultrahigh-Depth Sequencing in a Patient With Coronavirus Disease 2019 and Neurological Dysfunction

机译:案例报告:通过冠状病毒疾病的患者患者鉴定脑脊液中的SARS-COV-2,2019年患者和神经功能障碍

获取原文
           

摘要

We reported that the complete genome sequence of SARS-Coronavirus-2 (SARS-CoV-2) was obtained from a cerebrospinal fluid (CSF) sample by ultrahigh-depth sequencing. Fourteen days after onset, seizures, maxillofacial convulsions, intractable hiccups and a significant increase in intracranial pressure developed in an adult coronavirus disease 2019 patient. The complete genome sequence of SARS-CoV-2 obtained from the cerebrospinal fluid indicates that SARS-CoV-2 can invade the central nervous system. In future, along with nervous system assessment, the pathogen genome detection and other indicators are needed for studying possible nervous system infection of SARS-CoV-2.
机译:我们报道,通过超高深度测序从脑脊髓液(CSF)样品获得SARS-CORONAVIRUS-2(SARS-COV-2)的完整基因组序列。 发病后的十四天,癫痫发作,颌面抽搐,顽固的打嗝和成人冠状病毒疾病2019年患者的颅内压力显着增加。 从脑脊髓液中获得的SARS-COV-2的完整基因组序列表明SARS-COV-2可以侵入中枢神经系统。 将来,随着神经系统评估,研究病原体基因组检测和其他指标用于研究SARS-COV-2可能的神经系统感染。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号